Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.60 |
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.59 |
| ▸ | AKR1B10 | O60218 | 6/20 | 0.58 |
| ▸ | AKR1B1 | P15121 | 6/20 | 0.58 |
| ▸ | ESR1 | P03372 | 1/20 | 0.55 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | APP | P05067 | 5/20 | 0.50 |
| ▸ | MAOB | P27338 | 1/20 | 0.50 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA4 | P22748 | 1/20 | 0.47 |
| ▸ | CA6 | P23280 | 1/20 | 0.47 |
| ▸ | CA5A | P35218 | 1/20 | 0.47 |
| ▸ | CA7 | P43166 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6567707 | 0.99 | ALDH1A1 (0.59) | ALDH1A1LMNATDP1AKR1B10AKR1B1 | |
| SCHEMBL5013115 | 0.96 | ALDH1A1 (0.61) | ALDH1A1LMNATDP1AKR1B10AKR1B1 | |
| SCHEMBL81836 | 0.90 | LMNA (0.72) | ALDH1A1LMNATDP1AKR1B10AKR1B1 | |
| SCHEMBL81835 | 0.90 | LMNA (0.72) | ALDH1A1LMNATDP1AKR1B10AKR1B1 | |
| SCHEMBL29817892 | 0.89 | ESR1 (0.49) | ALDH1A1LMNATDP1AKR1B10AKR1B1 | |
| Methyl Alcohol SCHEMBL21995794 | 0.88 | LMNA (0.70) | ALDH1A1LMNATDP1AKR1B10AKR1B1 | |
| Myristic Acid SCHEMBL27577976 | 0.88 | APP (0.52) | ALDH1A1LMNATDP1AKR1B10AKR1B1 | |
| SCHEMBL15347088 | 0.88 | AKR1B10 (0.73) | ALDH1A1LMNAAKR1B10AKR1B1MEN1 | |
| SCHEMBL13834132 | 0.88 | AKR1B10 (0.73) | ALDH1A1LMNAAKR1B10AKR1B1MEN1 | |
| SCHEMBL24691226 | 0.88 | LMNA (0.59) | ALDH1A1LMNATDP1AKR1B10AKR1B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9730875-B2 | Photolabile pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2017-08-15 | — | — | US | disclosed |
| US-9458081-B2 | Photolabile pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2016-10-04 | — | — | US | disclosed |
| US-20160143829-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA | 2016-05-26 | — | — | US | disclosed |
| US-9284261-B2 | Photolabile pro-fragrances | HENKEL AG & CO. KGAA (DE) | 2016-03-15 | — | — | US | disclosed |
| US-20150099810-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2015-04-09 | — | — | US | disclosed |
| US-20150099809-A1 | PHOTOLABILE PRO-FRAGRANCES | HENKEL AG & CO. KGAA (DE) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150099809-A1 | PHOTOLABILE PRO-FRAGRANCES | TRPA1, PSAP, CRY1 | ALDH1A1 236/4885LMNA 1058/4885TDP1 3807/4885 |
| US-20150099810-A1 | PHOTOLABILE PRO-FRAGRANCES | TRPA1, PSAP, CRY1 | ALDH1A1 234/4885LMNA 1414/4885TDP1 4021/4885 |
| US-20160143829-A1 | PHOTOLABILE PRO-FRAGRANCES | TRPA1, PSAP, CRY1 | ALDH1A1 234/4885LMNA 1414/4885TDP1 4021/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.